MINT-BETAHISTINE DIN 02538156
Status: Marketed
Holder: MINT PHARMACEUTICALS INC
Molecule: BETAHISTINE HYDROCHLORIDE
Available to quote
Health Canada record
| Active ingredient(s) | BETAHISTINE HYDROCHLORIDE 24 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N07CA01 BETAHISTINE |
| Original market date | 31-Oct-2023 |
| Current status date | 31-Oct-2023 |
| Source | Health Canada DPD |
Establishment licence of the holder
Mint Pharmaceuticals Inc — licence 101613, currently licensed, last inspection rating C (2023-01-16).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing BETAHISTINE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02427966 | APO-BETAHISTINE | APOTEX INC | Tablet | BETAHISTINE HYDROCHLORIDE 8 MG | Approved |
| 02427982 | APO-BETAHISTINE | APOTEX INC | Tablet | BETAHISTINE HYDROCHLORIDE 24 MG | Approved |
| 02427974 | APO-BETAHISTINE | APOTEX INC | Tablet | BETAHISTINE HYDROCHLORIDE 16 MG | Approved |
| 02449145 | AURO-BETAHISTINE | AURO PHARMA INC | Tablet | BETAHISTINE HYDROCHLORIDE 8 MG | Marketed |
| 02449161 | AURO-BETAHISTINE | AURO PHARMA INC | Tablet | BETAHISTINE HYDROCHLORIDE 24 MG | Marketed |
| 02449153 | AURO-BETAHISTINE | AURO PHARMA INC | Tablet | BETAHISTINE HYDROCHLORIDE 16 MG | Marketed |
| 02525011 | BETAHISTINE | SANIS HEALTH INC | Tablet | BETAHISTINE HYDROCHLORIDE 8 MG | Approved |
| 02516888 | BETAHISTINE | SURAX HEALTHCARE INC | Tablet | BETAHISTINE HYDROCHLORIDE 24 MG | Approved |
| 02516861 | BETAHISTINE | SURAX HEALTHCARE INC | Tablet | BETAHISTINE HYDROCHLORIDE 16 MG | Approved |
| 02516853 | BETAHISTINE | SURAX HEALTHCARE INC | Tablet | BETAHISTINE HYDROCHLORIDE 8 MG | Approved |
| 02519682 | M-BETAHISTINE | MANTRA PHARMA INC | Tablet | BETAHISTINE HYDROCHLORIDE 8 MG | Marketed |
| 02519704 | M-BETAHISTINE | MANTRA PHARMA INC | Tablet | BETAHISTINE HYDROCHLORIDE 24 MG | Marketed |
| 02519690 | M-BETAHISTINE | MANTRA PHARMA INC | Tablet | BETAHISTINE HYDROCHLORIDE 16 MG | Marketed |
| 02538148 | MINT-BETAHISTINE | MINT PHARMACEUTICALS INC | Tablet | BETAHISTINE HYDROCHLORIDE 16 MG | Marketed |
| 02538121 | MINT-BETAHISTINE | MINT PHARMACEUTICALS INC | Tablet | BETAHISTINE HYDROCHLORIDE 8 MG | Marketed |
| 02544946 | NRA-BETAHISTINE | NORA PHARMA INC | Tablet | BETAHISTINE HYDROCHLORIDE 24 MG | Marketed |
| 02544911 | NRA-BETAHISTINE | NORA PHARMA INC | Tablet | BETAHISTINE HYDROCHLORIDE 8 MG | Marketed |
| 02544938 | NRA-BETAHISTINE | NORA PHARMA INC | Tablet | BETAHISTINE HYDROCHLORIDE 16 MG | Marketed |
| 02243878 | SERC | BGP PHARMA ULC | Tablet | BETAHISTINE HYDROCHLORIDE 16 MG | Marketed |
| 02247998 | SERC | BGP PHARMA ULC | Tablet | BETAHISTINE HYDROCHLORIDE 24 MG | Marketed |
| 02280191 | TEVA-BETAHISTINE | TEVA CANADA LIMITED | Tablet | BETAHISTINE HYDROCHLORIDE 16 MG | Marketed |
| 02280183 | TEVA-BETAHISTINE | TEVA CANADA LIMITED | Tablet | BETAHISTINE HYDROCHLORIDE 8 MG | Marketed |
| 02280205 | TEVA-BETAHISTINE | TEVA CANADA LIMITED | Tablet | BETAHISTINE HYDROCHLORIDE 24 MG | Marketed |
| 02374757 | ACT BETAHISTINE | ACTAVIS PHARMA COMPANY | Tablet | BETAHISTINE HYDROCHLORIDE 16 MG | Cancelled Post Market |
| 02374765 | ACT BETAHISTINE | ACTAVIS PHARMA COMPANY | Tablet | BETAHISTINE HYDROCHLORIDE 24 MG | Cancelled Post Market |
| 02466449 | BETAHISTINE | SANIS HEALTH INC | Tablet | BETAHISTINE HYDROCHLORIDE 16 MG | Dormant |
| 02466457 | BETAHISTINE | SANIS HEALTH INC | Tablet | BETAHISTINE HYDROCHLORIDE 24 MG | Dormant |
| 02330210 | PMS-BETAHISTINE | PHARMASCIENCE INC | Tablet | BETAHISTINE HYDROCHLORIDE 16 MG | Dormant |
| 02330237 | PMS-BETAHISTINE | PHARMASCIENCE INC | Tablet | BETAHISTINE HYDROCHLORIDE 24 MG | Dormant |
| 02222035 | SERC - TAB 4MG | SOLVAY PHARMA INC | Tablet | BETAHISTINE HYDROCHLORIDE 4 MG | Cancelled Post Market |
| 00193631 | SERC 4MG | UNIMED CANADA INC. | Tablet | BETAHISTINE HYDROCHLORIDE 4 MG | Cancelled Post Market |
| 02240601 | SERC 8 MG | SOLVAY PHARMA INC | Tablet | BETAHISTINE HYDROCHLORIDE 8 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 30891 | 2023-06-01 | Abbreviated New Drug Submission (ANDS) |
International API supply for BETAHISTINE HYDROCHLORIDE
2 active FDA Drug Master Files.
Request a quote for MINT-BETAHISTINE